Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT02387593
Other study ID # END-1302-14/15-1
Secondary ID
Status Unknown status
Phase N/A
First received March 9, 2015
Last updated March 12, 2015
Start date September 2014

Study information

Verified date September 2014
Source Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Contact Rafael RB Barreto Zúñiga, MD
Phone 0155- 54870900
Email barretozu@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. The cumulative risk of developing CRC is about 6% lifelong.

The benefit of screening colonoscopy depends on the detection and removal of all adenomas, however, some of these may be difficult to detect.

The "endocuff" (EC) is a polymer sleeve which joins the tip of the colonoscope to improve the image viewing of the mucosa during colonoscopy procedure.

There is insufficient evidence of the usefulness of endocuf


Description:

All patients requiring colonoscopy for screening and who agree to participate in the study will be included and randomized them to make an standard colonoscopy or colonoscopy with endocuff, for randomization system will be used in balanced blocks of 4, created on the page randomization.com.


Recruitment information / eligibility

Status Unknown status
Enrollment 300
Est. completion date
Est. primary completion date April 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Healthy adult patients,

- Aged 18,

- Who would come to colonoscopy for colon cancer screening without prior colonoscopy studies

Exclusion Criteria:

- Boston colonic preparation <5 points

- Suspected Lynch syndrome or familial adenomatous polyposis (FAP)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ENDOCUFF
One endocuff device is placed at the tip of colonoscope prior to colonoscopy baseline

Locations

Country Name City State
Mexico Rafael Barreto México Tlalpan

Sponsors (1)

Lead Sponsor Collaborator
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Country where clinical trial is conducted

Mexico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adenoma detection rate Percentage of adenomas detected during colonoscopy 30 minutes
Primary Measurement of the polyp detection rate Percentage of polyps detected during colonoscopy 30 minutes
Secondary Cecal intubation rate Percentage of cecal intubation 30 minutes
Secondary ileal intubation rate Percentage of ileal intubation 10 minutes
Secondary Difficulty performing polypectomy When the endoscopist requiring special maneuvers to perform polypectomy 10 minutes
Secondary Complications during colonoscopy When patients require special handling during or immediately subsequent colonoscopy One week